These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 32513535)

  • 1. Pidotimod enhanced the anti-growth effect of cisplatin on lung cancer in mice via promoting anti-tumor immune response.
    Wu T; Cui J; Gao J; Zhou H; Li A; Guo W
    Biochem Biophys Res Commun; 2020 Aug; 528(4):678-684. PubMed ID: 32513535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pidotimod promotes functional maturation of dendritic cells and displays adjuvant properties at the nasal mucosa level.
    Giagulli C; Noerder M; Avolio M; Becker PD; Fiorentini S; Guzman CA; Caruso A
    Int Immunopharmacol; 2009 Nov; 9(12):1366-73. PubMed ID: 19712757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pidotimod in allergic diseases.
    Manti S; Parisi GF; Papale M; Leonardi S
    Minerva Pediatr; 2020 Oct; 72(5):358-363. PubMed ID: 32731733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic immunostimulating activity of pidotimod and red ginseng acidic polysaccharide against cyclophosphamide-induced immunosuppression.
    Du XF; Jiang CZ; Wu CF; Won EK; Choung SY
    Arch Pharm Res; 2008 Sep; 31(9):1153-9. PubMed ID: 18806958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pidotimod and Immunological Activation in Individuals Infected with HIV.
    Ucciferri C; Falasca K; Reale M; Tamburro M; Auricchio A; Vignale F; Vecchiet J
    Curr HIV Res; 2021; 19(3):260-268. PubMed ID: 33430735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pidotimod. A new biological response modifier. Introduction.
    Maillard F
    Arzneimittelforschung; 1994 Dec; 44(12A):1399-401. PubMed ID: 7857330
    [No Abstract]   [Full Text] [Related]  

  • 7. Pidotimod for the prevention of acute respiratory infections in healthy children entering into daycare: A double blind randomized placebo-controlled study.
    Mameli C; Pasinato A; Picca M; Bedogni G; Pisanelli S; Zuccotti GV;
    Pharmacol Res; 2015 Jul; 97():79-83. PubMed ID: 25931316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pidotimod: a reappraisal.
    Riboldi P; Gerosa M; Meroni PL
    Int J Immunopathol Pharmacol; 2009; 22(2):255-62. PubMed ID: 19505378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pidotimod may prevent recurrent respiratory infections in children.
    Licari A; De Amici M; Nigrisoli S; Marseglia A; Caimmi S; Artusio L; Marseglia GL
    Minerva Pediatr; 2014 Oct; 66(5):363-7. PubMed ID: 25253184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic immunostimulatory effect of pidotimod and red ginseng acidic polysaccharide on humoral immunity of immunosuppressed mice.
    Du Xiao F; Jiang CZ; Wu CF; Won EK; Choung SY
    Pharmazie; 2008 Dec; 63(12):904-8. PubMed ID: 19177908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological hallmarks of cis-DDP-resistant Lewis lung carcinoma cells.
    Fedorchuk O; Susak Y; Rudyk M; Senchylo N; Khranovska N; Skachkova O; Skivka L
    Cancer Chemother Pharmacol; 2018 Feb; 81(2):373-385. PubMed ID: 29290023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Pidotimod on recurrent respiratory infections in children with Down syndrome: a retrospective Italian study.
    Valentini D; Di Camillo C; Mirante N; Marcellini V; Carsetti R; Villani A
    Ital J Pediatr; 2020 Mar; 46(1):31. PubMed ID: 32164747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Potentiation of the resistance to viral and bacterial infections after pidotimod administration in mice].
    Marelli P; Lupetti A; Senesi S; Uslenghi C; Girardello R; Campa M
    Drugs Exp Clin Res; 1993; 19 Suppl():15-21. PubMed ID: 8625778
    [No Abstract]   [Full Text] [Related]  

  • 14. [Stimulation of B-cell immunity in the nude mice by pidotimod: immunohistochemical stucy of various lymphoid organs].
    Vacca A; Di Stefano R; Caloro D; Ranieri G; Dammacco F
    Drugs Exp Clin Res; 1993; 19 Suppl():23-6. PubMed ID: 8625779
    [No Abstract]   [Full Text] [Related]  

  • 15. Carnosic acid enhances the anti-lung cancer effect of cisplatin by inhibiting myeloid-derived suppressor cells.
    Liu W; Wu TC; Hong DM; Hu Y; Fan T; Guo WJ; Xu Q
    Chin J Nat Med; 2018 Dec; 16(12):907-915. PubMed ID: 30595215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulatory activity of pidotimod administered with standard antibiotic therapy in children hospitalized for community-acquired pneumonia.
    Esposito S; Garziano M; Rainone V; Trabattoni D; Biasin M; Senatore L; Marchisio P; Rossi M; Principi N; Clerici M
    J Transl Med; 2015 Sep; 13():288. PubMed ID: 26335787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pidotimod exacerbates allergic pulmonary infection in an OVA mouse model of asthma.
    Fu LQ; Li YL; Fu AK; Wu YP; Wang YY; Hu SL; Li WF
    Mol Med Rep; 2017 Oct; 16(4):4151-4158. PubMed ID: 28731127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulating activity of Pidotimod in children with Down syndrome.
    Zuccotti GV; Mameli C; Trabattoni D; Beretta S; Biasin M; Guazzarotti L; Clerici M
    J Biol Regul Homeost Agents; 2013; 27(1):253-8. PubMed ID: 23489705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of pidotimod and bifidobacteria mixture on clinical symptoms and urinary metabolomic profile of children with recurrent respiratory infections: a randomized placebo-controlled trial.
    Santamaria F; Montella S; Stocchero M; Pirillo P; Bozzetto S; Giordano G; Poeta M; Baraldi E
    Pulm Pharmacol Ther; 2019 Oct; 58():101818. PubMed ID: 31302340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pidotimod, an immunostimulant in pediatric recurrent respiratory tract infections: A meta-analysis of randomized controlled trials.
    Niu H; Wang R; Jia YT; Cai Y
    Int Immunopharmacol; 2019 Feb; 67():35-45. PubMed ID: 30530167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.